German drugmaker Merck steps up push into biosimilars

09-02-2014 Financial TimesComments (0)

BiosimilarsMerck KGaA

Karl-Ludwig Kley, chief executive of the German group, said that he expected “biosimilars” – cheaper copies of expensive biological drugs – to become an important new market as governments around the world seek to lower healthcare costs.

Read more on Financial Times

Your Comments

Login to add a comment

There are no comments yet. Be the first and leave a response!

Back to top